SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-008478
Filing Date
2021-04-12
Accepted
2021-04-12 08:07:24
Documents
1
Period of Report
2021-04-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 33020
  Complete submission text file 0001493152-21-008478.txt   34295
Mailing Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024 201-464-2677
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36602 | Film No.: 21819447
SIC: 2834 Pharmaceutical Preparations